Company profile
Anchored In LTD.
Join PIC Bootcamp | Practical Training in Photonic Integrated Circuits | Enroll Today
PIC Bootcamp offers practical training in photonic integrated circuits. Join PIC Bootcamp for hands-on experience in PICs. Enroll now!
Latest accounts
Financial period: 1 Apr 2024 to 31 Mar 2025
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQzNDc3NjQ5NWFkaXF6a2N4
Published 06 Sep 2024 12:14
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Phorwards21
1 Jan 2024 to 31 Dec 2026
Phorwards21 will create and implement a comprehensive industrial strategy for photonics in Europe. The action will be implemented by Photonics21 (the EU Commission's partner in the Horizon Europe Photonics Partnership) with its more than 3000 members from companies and research institutions as well as national photonics technology platforms and regional c...
Photonic Integrated Circuit Bootcamp
1 Sep 2023 to 28 Feb 2025
We propose an intense training course to reskill professionals in the growing Photonics Integrated Circuit (PIC) technology sector. Three companies and two universities have teamed up to develop a hands-on course covering the entire PIC creation process, including design, fabrication, testing, and packaging, using industry tools and standards. The course ...
eScent mask for personal protective assurance: a human-centred approach to PPE in the post COVID-19 world
1 Oct 2020 to 31 Jul 2021
The panic around coronavirus has resulted in global demand for masks. The trauma associated with COVID-19 has led to the deaths of many healthcare staff. Recent research published in Cell \[1\] suggests that SARs-CoV-2 infects cells of the respiratory tract with the nose being the dominant site from which lung infections begin. This opens new directions f...